News

iSTAR Medical Secures €10 Million Financing

WAVRE, Belgium — 12 April 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the closing of a €10 million Series B equity financing. Existing shareholders including Capricorn Venture Partners and Walloon Region Investment Fund (SRIW) contributed to the round, which was joined by […]

iSTAR Medical Appoints Medical Device Executive Michel Lussier as Chairman of its Board of Directors

ISNES, Belgium, April 27, 2015 /PRNewswire/ — iSTAR Medical SA, a Belgium ophthalmic device company, announced today the appointment of Michel Lussier as Chairman of the company’s Board of Directors.

iStar Medical Announces First Patient Implanted with STARflo™ Glaucoma Drainage Device in European Clinical Trial

Isnes, Belgium (Oct 30, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that the first patient in its European multi-center clinical trial has been successfully implanted with the STARflo™ glaucoma drainage device.

News Michel

iSTAR Medical appoints Michel Vanbrabant Chief Executive Officer

Isnes, Belgium (July 16, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that Michel Vanbrabant has been appointed Chief Executive Officer and member of the Board of Directors.

iSTAR Medical Adds Glaucoma Pioneer Prof. Michael Belkin, MD, to Scientific Advisory Board

Isnes, Belgium (April 29, 2014) – iSTAR Medical SA (iSTAR), a medical device company specializing in ophthalmic implants, announced today the addition of Prof. Michael Belkin, MD, to its Scientific Advisory Board (SAB). Prof. Belkin is professor emeritus of Ophthalmology at Tel-Aviv University where he is the director of the Ophthalmic Technologies Laboratory at the […]